Evidence map›Paper›PMID 31005648›Full record

ArticleJournal of geriatric oncology2020

Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE).

Grant R Williams, Kelly M Kenzik, Mariel Parman, Mustafa Al-Obaidi, Liton Francisco, Gabrielle B Rocque, Andrew McDonald, Ravi Paluri, Rudolph M Navari, Lakshmin Nandagopal and 4 more

Abstract read
In one paragraph

Article in Journal of geriatric oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Grant R WilliamsInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, United Kingdom; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom. Electronic address: gwillia@uab.edu.
Kelly M KenzikInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, United Kingdom; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom.
Mariel ParmanInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, United Kingdom.
Mustafa Al-ObaidiInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, United Kingdom.
Liton FranciscoInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, United Kingdom.
Gabrielle B RocqueDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom.
Andrew McDonaldInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, United Kingdom.
Ravi PaluriDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom.
Rudolph M NavariDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom.
Lakshmin NandagopalDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom.
Olumide GbolahanDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom.
Crystal Young-SmithDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom.
Matthew RobertsonDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, United Kingdom.
Smita BhatiaInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, United Kingdom.

Funding

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M StudyK08CA234225 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAMS, GRANT R · 2018 to 2022
$1.0M
NCI NIH HHS K08 CA234225
6 · The paper itself

Abstract

backgroundIntegrating Geriatric Assessment (GA) in the management of older adults with cancer is recommended, yet rarely practiced in routine oncologic care. Our objective was to assess the feasibility of integrating routine GA in the management of older adults with gastrointestinal (GI) malignancies and characterize impairments in this population.

methodsPatients ≥60yo referred for consultation to the GI Oncology clinic were asked to complete the Cancer and Aging Resilience Evaluation (CARE) on their first visit. CARE was adapted from the Cancer and Aging Research Group GA with modifications to create a completely patient-reported version of the GA. Feasibility was defined as completion of CARE by ≥80% of eligible patients during the initial consultation.

resultsOf the eligible 354 new patients seen in the GI Oncology Clinic, 323 (91.2%) completed the CARE survey. Most patients (83.1%) felt the length of time to complete was appropriate (median time of 10 min [IQR 10-15.7 min]). GA impairments were prevalent: 54.7% reported dependence in Instrumental Activities of Daily Living, 15.5% reported dependence in Activities of Daily Living, 20.9% reported ≥1 fall, 35.9% reported a performance status ≥2, 55.7% were limited in walking one block, 74.0% reported polypharmacy (≥4 medications), and 36.4% had ≥3 comorbidities.

conclusionsPerforming a GA in the routine care of older adults with GI malignancies is feasible, and GA impairments are common among this population. A fully patient-reported GA such as the CARE may facilitate broader incorporation of GA in the routine clinic work flow.

Indexed as

Gastrointestinal NeoplasmsNeoplasmsActivities of Daily LivingAgedAgingGeriatric AssessmentHumansReferral and ConsultationAgedCancerGastrointestinal malignancyGeriatric assessmentGeriatric oncology

Identifiers

PMID31005648
PMCPMC6801013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.